Alpha Mark Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpha Mark Advisors, LLC

$290 Million
Q3 2024

A detailed history of Alpha Mark Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 1,613 shares of REGN stock, worth $1.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

1,613

Previous 1,685 4.27%

Holding current value

$1.2 Million

Previous $1.77 Million 4.23%

% of portfolio

0.59%

Previous 0.62%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$1024.09 - $1201.76 $73,734 - $86,526	-72 Reduced 4.27%	1,613 $1.7 Million
Q2 2024 Jul 17, 2024	SELL	$883.2 - $1071.19 $49,459 - $59,986	-56 Reduced 3.22%	1,685 $1.77 Million
Q1 2024 Apr 18, 2024	SELL	$902.69 - $993.35 $75,825 - $83,441	-84 Reduced 4.6%	1,741 $1.68 Million
Q4 2023 Jan 19, 2024	SELL	$775.18 - $881.7 $2,325 - $2,645	-3 Reduced 0.16%	1,825 $1.6 Million
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $43,624 - $53,195	-63 Reduced 3.33%	1,828 $1.5 Million
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $296,812 - $352,068	-424 Reduced 18.32%	1,891 $1.36 Million
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $17,012 - $20,674	25 Added 1.09%	2,315 $1.9 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 0.43%	2,290 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $43,047 - $54,324	75 Added 3.37%	2,300 $1.58 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $4,935 - $6,649	9 Added 0.41%	2,225 $1.32 Million
Q1 2022 May 02, 2022	SELL	$595.12 - $698.43 $60,107 - $70,541	-101 Reduced 4.36%	2,216 $1.55 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $26,087 - $32,206	48 Added 2.12%	2,317 $1.46 Million
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $3,444 - $4,085	-6 Reduced 0.26%	2,269 $1.37 Million
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $8,037 - $9,495	-17 Reduced 0.74%	2,275 $1.27 Million
Q1 2021 Apr 29, 2021	SELL	$446.73 - $548.2 $52,714 - $64,687	-118 Reduced 4.9%	2,292 $1.08 Million
Q4 2020 Feb 01, 2021	SELL	$478.3 - $607.98 $896,812 - $1.14 Million	-1,875 Reduced 43.76%	2,410 $1.16 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $600,859 - $726,005	-1,103 Reduced 20.47%	4,285 $2.4 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $14,306 - $18,673	29 Added 0.54%	5,388 $3.36 Million
Q1 2020 Apr 24, 2020	SELL	$336.18 - $494.43 $915,081 - $1.35 Million	-2,722 Reduced 33.68%	5,359 $2.62 Million
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $254,666 - $349,777	-929 Reduced 10.31%	8,081 $3.03 Million
Q3 2019 Nov 01, 2019	BUY	$273.46 - $318.39 $65,630 - $76,413	240 Added 2.74%	9,010 $2.5 Million
Q2 2019 Aug 02, 2019	BUY	$299.6 - $414.82 $367,010 - $508,154	1,225 Added 16.24%	8,770 $2.75 Million
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $2.79 Million - $3.3 Million	7,502 Added 17446.51%	7,545 $3.1 Million
Q3 2017 Nov 02, 2017	BUY	$431.38 - $504.0 $18,549 - $21,672	43	43 $19,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Account

Alpha Mark Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History